Provided Infusion and Injection Therapies

PURE treatments are sourced directly from the originating pharmaceutical manufacturer, through a participating Group Purchasing Organization (GPO). These biologic and bio-similar treatments, along with other available therapies, are administered in PURE facilities in accordance with the express guidelines outlined by their manufacturer. PURE's team of Doctors, Nurse Practitioners, Registered Nurses and Supervisors adhere to the well established protocols to ensure our patients safety and comfort during the administration of these treatments.

Actemra
(Tocilizumah)
Benlysta
(Belimumab)
Boniva
(Ibandronate)
Cerezyme
(Imiglucerase)
Cimzia
(Certolizumab)
Cinqair
(Reslizumab)
Entyvio
(Vedolizumab)
Evenity
(Romosozumab-aqqg)
Fabrazyme
(Agalsidase)
Fasenra
(Benralizumab)
Gammagard
[Immune Globulin Infusion (Human)]
Gamunex-C
(immune globulin injection [human] 10%)
Ilumya
(Tildrakizumab-Asmn)
Immune globulin IV
(IVIG)
Injectafer
(Ferric Carboxymaltose)
Krystexxa
(Pegloticase)
Lemtrada
(Alemtuzumab)
Methylprednisolone
Nucala
(Mepolizumab)
Nulojix
(Belatacept)
Ocrevus
(Ocrelizumab)
Onpattro
(Patisiran)
Orbactiv
(Oritavancin)
Orencia
(Abatacept)
Pamidronate
Prolia
(Denosumab)
Reclast
(Zoledronic Acid)
Remicade
(Infliximab, Inflectra, Renflexis, Ixifi, Avsola)
Rituxan
(Rituximab)
Simponi Aria
(Golimumab)
Soliris
(Eculizumab)
Spravato
(Esketamine)
Stelara IV
(Ustekinumab Intravenous Infusion)
Stelara SQ
(Ustekinumab Subcutaneous Injection)
Tepezza
(Teprotumumab)
Thyrogen
(Thyrotropin Alfa)
Tysabri
(Natalizumab)
Venofer
(Iron Sucrose Injection)
Vivitrol
(Naltrexone)
Vyepti
(eptinezumab-jjmr)
Xolair
(Omalizumab)
Zinplava
(Bezlotoxumab)